Cerebral venous sinus thrombosis associated with essential thrombocytosis in a pediatric patient

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 3, 2007, Pages 156-159

  Jensen, Ashley W ^a   Tefferi, Ayalew ^a   Arndt, Carola A S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Essential thrombocytosis; Hydroxyurea; Venous sinus thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYUREA; WARFARIN;

ADOLESCENT; ARTICLE; CASE REPORT; FOLLOW UP; HEADACHE; HUMAN; MALE; MUCOSA INFLAMMATION; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS; VEIN THROMBOSIS;

ADOLESCENT; ANTICOAGULANTS; ASPIRIN; BONE MARROW; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MUCOSITIS; PLATELET COUNT; SENSITIVITY AND SPECIFICITY; SINUS THROMBOSIS, INTRACRANIAL; THROMBOCYTOSIS; TREATMENT OUTCOME; WARFARIN;

EID: 34247576820     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3180377b9c     Document Type: Article

References (18)

1. Hasle H. Incidence of essential thrombocythaemia in children. Br J Haematol. 2000;110:751.
2. Walther EU, Tiecks FP, Haberl RL. Cranial sinus thrombosis associated with essential thrombocythemia followed by heparin-associated thrombocytopenia. Neurology. 1996;47:300-301.
3. McDonald TD, Tatemichi TK, Kranzler SJ, et al. Thrombosis of the superior sagittal sinus associated with essential thrombocytosis followed by MRI during anticoagulant therapy. Neurology. 1989;39:1554-1555.
4. Iob I, Scanarini M, Andrioli GC, et al. Thrombosis of the superior sagittal sinus associated with idiopathic thrombocytosis. Surg Neurol. 1979;11:439-441.
5. Murphy MF, Clarke CR, Brearley RL. Superior sagittal sinus thrombosis and essential thrombocythaemia. Br Med J (Clin Res Ed). 1983;287:1344.
6. Mitus AJ, Barbui T, Shulman LN, et al. Hemostatic complications in young patients with essential thrombocythemia. Am J Med. 1990;88:371-375.
7. Randi ML, Putti MC. Essential thrombocythaemia in children: is a treatment needed? Expert Opin Pharmacother. 2004;5:1009-1014.
8. Dror Y, Zipursky A, Blanchette VS. Essential thrombocythemia in children (see comment). J Pediatr Hematol Oncol. 1999;21:356-363.
9. Sebire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005;128:477-489.
10. Barbui T. Indications for lowering platelet numbers in essential thrombocythemia. Semin Hematol. 2003;40:22-25.
11. Harrison CN, Campbell PJ, Buck G, et al. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia (see comment). N Engl J Med. 2005;353:33-45.
12. Cortelazzo S, Finazzi G, Ruggeri M, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis (see comment). N Engl J Med. 1995;332:1132-1136.
13. Weinfeld A, Swolin B, Westin J. Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications. Eur J Haematol. 1994;52:134-139.
14. Sterkers Y, Preudhomme C, Lai JL, et al. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. (see comment). Blood. 1998;91:616-622.
15. Liozon E, Brigaudeau C, Trimoreau F, et al. Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature. Hematol Cell Ther. 1997;39:11-18.
16. Finazzi G, Ruggeri M, Rodeghiero F, et al. Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosis (see comment). Blood. 2003;101:3749.
17. Benkerrou M, Delarche C, Brahimi L, et al. Hydroxyurea corrects the dysregulated L-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia. Blood. 2002;99:2297-2303.
18. Falanga A, Marchetti M, Evangelista V, et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood. 2000;96:4261-4266.